AsymmetRx Medical Overview
- Founded
- 2001
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
AsymmetRx Medical General Information
Description
Developer of drug and medical devices. The company has developed p63 gene which is involved in the diagnosis of prostate cancer and many other cancers.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Other Devices and Supplies
Primary Office
- 100 Powder Mill Road
- Suite 177
- Acton, MA 01720
- United States
+1 (617) 000-0000
AsymmetRx Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
AsymmetRx Medical Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Peter McKeon | President & Board Member | ||
| Frank McKeon Ph.D | Executive | ||
| Matthew Vincent Ph.D | Executive |
AsymmetRx Medical Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Peter McKeon | AsymmetRx Medical | President & Board Member | 000 0000 |
AsymmetRx Medical Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |